Novel Antithrombotic Agents in Pregnancy Anticoagulants and Antiplatelet Agents.

Increasing rates of thromboembolic complications have required increasing use of anticoagulant and antiplatelet agents during and after pregnancy. Furthermore, thromboembolism is both a cause and a complication of severe maternal morbidity requiring intensive care. As a consequence, almost all patients admitted to intensive care units receive an anticoagulant or an antiplatelet agent (or both) for either treatment or prevention of thromboembolism. In this review, we summarize commonly used anticoagulants and antiplatelet agents and outline the potential role of newly developed (novel) antithrombotic agents for pregnant and postpartum patients.

Duke Scholars

Author Andra Hohler James Obstetrics and Gynecology, Maternal Fetal Medicine

Author Ronan Paul Sugrue Obstetrics and Gynecology, Maternal Fetal Medicine

Author Jerome Jeffrey Federspiel Obstetrics and Gynecology, Maternal Fetal Medicine